Biowest USA Inc.

Bradenton, FL

UEI
TUDHCZJLM1S1
CAGE
9B8W6
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
3135 Lakewood Ranch Blvd, Bradenton, FL 34211, USA
Website
biowestusa.com
Founded
1987
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $16,110
FY2024 $82,468

Contract awards

Similar vendors

About the company

Biowest USA Inc. is a for-profit corporate entity registered in SAM.gov, located in Bradenton, Florida, that specializes in providing biological products, with a primary focus on supplying fetal bovine serum to various research and scientific institutions. The company's core business involves manufacturing biological materials that support biomedical research across multiple scientific domains, serving critical research needs within federal agencies. As a registered federal contractor, Biowest USA Inc. has demonstrated expertise in delivering high-quality biological products to specialized research institutions, maintaining an active federal contracting presence since at least 2022.

The company has secured multiple federal contract awards primarily from agencies within the Department of Health and Human Services, including the National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute, National Institute of Dental and Craniofacial Research, and Veterans Integrated Service Network 1. These contracts, ranging in value from approximately $12,000 to $24,700, have been predominantly firm fixed-price purchase orders for fetal bovine serum with specific research applications. Most contracts have not been set aside, with one exception being a small business set-aside award from the National Institute of Allergy and Infectious Diseases. The serum purchased through these contracts supports diverse research initiatives, including T-cell activation studies, immunology research, infectious disease investigations, and potentially dental and craniofacial complex research. Each contract typically specifies precise serum lot requirements, such as USDA origin, and has performance periods ranging from mid-2024 to mid-2026.

Quick answers

Is Biowest USA Inc. registered in SAM.gov?

Yes. Biowest USA Inc.'s SAM.gov registration is active through May 11, 2027.

What is Biowest USA Inc.'s CAGE code?

Biowest USA Inc.'s CAGE code is 9B8W6, and its Unique Entity ID (UEI) is TUDHCZJLM1S1.

How much has Biowest USA Inc. received in federal contracts?

Federal contracts obligated $16,110 to Biowest USA Inc. in fiscal year 2025 and $98,578 in fiscal years 2023 through 2027.

How does Biowest USA Inc. rank among federal contractors?

Biowest USA Inc. ranked #97 in NAICS 325414 in FY2025.

What is Biowest USA Inc.'s most recent federal award?

Biowest USA Inc.'s most recent federal contract award is Purchase of fetal bovine serum lot # 067U22 (36C24125P0733), from Veterans Integrated Service Network 1 (VHA), on August 1, 2025.

On GovTribe

See Biowest USA Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe